Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Despite over 1,200 risk genes linked to autism, new research suggests the brain's response may fall into just two opposing molecular patterns. Scientists analyzed more than 1,000 mouse brain transcriptomes and found that genetically distinct autism models cluster into two groups with mirror-image gene activity changes. The discovery could reshape how researchers study autism biology and test experimental treatments.
Autism spectrum disorder (ASD) is linked to more than 1,200 risk genes — a staggering diversity that has long made it hard to find common biological ground. Now, a team from the Institute for Basic Science (IBS) in South Korea has found that, despite this genetic variety, the brain's molecular response to autism-risk mutations may converge into just two opposing patterns.
Analyzing RNA-sequencing data from 17 genetically engineered mouse lines — covering over 1,000 brain transcriptomes — researchers identified two broad molecular groups. In Group 1, synaptic communication genes were underexpressed while chromatin regulation genes were overexpressed. Group 2 showed the exact opposite. Crucially, the grouping wasn't fixed: the same mutation could land a male mouse in one group and a female in another, and patterns shifted with developmental stage and brain region.
The two groups also responded differently to fluoxetine and lithium, two drugs previously studied in autism mouse models. Group 1 showed more consistent gene-expression shifts toward control patterns; Group 2 was more variable. Preliminary human data from 40 autistic individuals hinted at similar subgroupings, though immune-related differences were more prominent in humans.
Key Takeaways:
Why it matters: This framework could help researchers move beyond gene-by-gene analysis toward shared biological mechanisms — a critical step for developing therapies that work across ASD's vast genetic landscape.
